FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.

FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2006 Nov 15;74(10):1685.

The article “Medications for Migraine Prophylaxis” (January 1, 2006, page 72) contained an error in the section titled “Pregnancy” on page 77. The second sentence of this section incorrectly listed fluoxetine (Prozac) as a U.S. Food and Drug Administration (FDA) pregnancy category B drug, and that it could be considered for preventive therapy of chronic migraine in women who are pregnant. In March 1997, the FDA reclassified fluoxetine as a pregnancy category C drug, and it should be used with the same caution as all pregnancy category C drugs in women who are pregnant. The online version of this article has been corrected.

Copyright © 2006 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

Article Tools

  • Print page
  • Share this page

Information From Industry

Navigate this Article